Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 15, 2010
Urinary proteome profiling using 2D-DIGE and LC-MS/MS
Mark E Weeks
Advances in Nutrition (Bethesda, Md.)
|
February 15, 2012
Proteomics and systems biology: current and future applications in the nutritional sciences
J Bernadette Moore, Mark E Weeks
Methods in Molecular Biology (Clifton, N.J.)
|
November 3, 2009
Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE)
Deepak Hariharan, Mark E Weeks, Tatjana Crnogorac-Jurcevic
Proteomics
|
January 20, 2004
Global changes in gene expression observed at the transition from growth to stationary phase in Listeria monocytogenes ScottA batch culture
Mark E Weeks, David C James, Gary K Robinson, et al.
The FEBS Journal
|
September 26, 2006
Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma
Daniel E Alete, Mark E Weeks, Ara G Hovanession, et al.
Biochimica Et Biophysica Acta
|
September 2, 2006
Mass spectrometry identification of circulating alpha-1-B glycoprotein, increased in aged female C57BL/6 mice
John R Stehle, Mark E Weeks, Kai Lin, et al.
Cancer Research
|
September 19, 2007
The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D
Hannah J Whiteman, Mark E Weeks, Sally E Dowen, et al.
Proteomics
|
March 25, 2005
Stress-induced changes in the Schizosaccharomyces pombe proteome using two-dimensional difference gel electrophoresis, mass spectrometry and a novel integrated robotics platform
Mark E Weeks, John Sinclair, Richard J Jacob, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma
Mark E Weeks, Deepak Hariharan, Ljiljana Petronijevic, et al.
Oncotarget
|
July 16, 2019
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
Alvin Y Liu, Adelle D Kanan, Tomasz P Radon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
September 15, 2010
Urinary proteome profiling using 2D-DIGE and LC-MS/MS
Mark E Weeks
Advances in Nutrition (Bethesda, Md.)
|
February 15, 2012
Proteomics and systems biology: current and future applications in the nutritional sciences
J Bernadette Moore, Mark E Weeks
Methods in Molecular Biology (Clifton, N.J.)
|
November 3, 2009
Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE)
Deepak Hariharan, Mark E Weeks, Tatjana Crnogorac-Jurcevic
Proteomics
|
January 20, 2004
Global changes in gene expression observed at the transition from growth to stationary phase in Listeria monocytogenes ScottA batch culture
Mark E Weeks, David C James, Gary K Robinson, et al.
The FEBS Journal
|
September 26, 2006
Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma
Daniel E Alete, Mark E Weeks, Ara G Hovanession, et al.
Biochimica Et Biophysica Acta
|
September 2, 2006
Mass spectrometry identification of circulating alpha-1-B glycoprotein, increased in aged female C57BL/6 mice
John R Stehle, Mark E Weeks, Kai Lin, et al.
Cancer Research
|
September 19, 2007
The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D
Hannah J Whiteman, Mark E Weeks, Sally E Dowen, et al.
Proteomics
|
March 25, 2005
Stress-induced changes in the Schizosaccharomyces pombe proteome using two-dimensional difference gel electrophoresis, mass spectrometry and a novel integrated robotics platform
Mark E Weeks, John Sinclair, Richard J Jacob, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma
Mark E Weeks, Deepak Hariharan, Ljiljana Petronijevic, et al.
Oncotarget
|
July 16, 2019
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
Alvin Y Liu, Adelle D Kanan, Tomasz P Radon, et al.
Page
of 2